Ventricular Arrhythmias in Acute Myocardial Infarction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPoitiers University Hospital
About this trial
Ventricular arrhythmias are a serious complication of myocardial infarction. The aim of this study is to provide reliable data on the management and mortality associated with ventricular arrhythmia in the setting of acute myocardial infarction.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥ 18 years
Acute myocardial infarction
Sustained ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation) at the acute phase of an acute myocardial infarction (before hospital discharge)
Between January 1, 2012 and April 14, 2024
Disqualifiers
None
Trial population
All included individuals will be consecutive patients who developed a sustained ventricular arrhythmia during the acute phase of a myocardial infarction between January 1, 2012, and April 14, 2024.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 1 trial groupGroup A: Ventricular arrhythmia
Trial outcomes
Primary outcomes
1
Post-discharge mortality
Time frame
through study completion, an average of 2 yearsSecondary outcomes
1
Baseline demographic and clinical characteristics at inclusion
This outcome is the characterization of the study population at baseline, including demographic, and clinical-related variables collected at the time of myocardial infarction.
Time frame
At baseline2
Number of participants fot each type of myocardial infarction
Includes revascularization strategy and other therapeutic management measures implemented during the index hospitalization.
Time frame
At baseline3
Number of participants with each ventricular arrhythmia characteristic and management strategy during index hospitalization
Descriptive summary of ventricular arrhythmia presentation and in-hospital management, including arrhythmia type, timing of occurrence, recurrence, and therapeutic interventions.
Time frame
At baseline4
In-hospital mortality
proportion of patients who die during their hospital stay, before discharge
Time frame
From admission until the date of death or hospital discharge, whichever came first, assessed up to 28 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov